149 related articles for article (PubMed ID: 36619276)
1. Digging deeper into the immunopeptidome: characterization of post-translationally modified peptides presented by MHC I.
Mangalaparthi KK; Madugundu AK; Ryan ZC; Garapati K; Peterson JA; Dey G; Prakash A; Pandey A
J Proteins Proteom; 2021; 12(3):151-160. PubMed ID: 36619276
[TBL] [Abstract][Full Text] [Related]
2. Immunopeptidomic Analysis Reveals That Deamidated HLA-bound Peptides Arise Predominantly from Deglycosylated Precursors.
Mei S; Ayala R; Ramarathinam SH; Illing PT; Faridi P; Song J; Purcell AW; Croft NP
Mol Cell Proteomics; 2020 Jul; 19(7):1236-1247. PubMed ID: 32357974
[TBL] [Abstract][Full Text] [Related]
3. Structural aspects of chemical modifications in the MHC-restricted immunopeptidome; Implications for immune recognition.
Sandalova T; Sala BM; Achour A
Front Chem; 2022; 10():861609. PubMed ID: 36017166
[TBL] [Abstract][Full Text] [Related]
4. Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma.
Qi YA; Maity TK; Cultraro CM; Misra V; Zhang X; Ade C; Gao S; Milewski D; Nguyen KD; Ebrahimabadi MH; Hanada KI; Khan J; Sahinalp C; Yang JC; Guha U
Mol Cell Proteomics; 2021; 20():100136. PubMed ID: 34391887
[TBL] [Abstract][Full Text] [Related]
5. High-resolution analysis of the murine MHC class II immunopeptidome.
Sofron A; Ritz D; Neri D; Fugmann T
Eur J Immunol; 2016 Feb; 46(2):319-28. PubMed ID: 26495903
[TBL] [Abstract][Full Text] [Related]
6. The biogenesis of the immunopeptidome.
Admon A
Semin Immunol; 2023 May; 67():101766. PubMed ID: 37141766
[TBL] [Abstract][Full Text] [Related]
7. Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors.
Kacen A; Javitt A; Kramer MP; Morgenstern D; Tsaban T; Shmueli MD; Teo GC; da Veiga Leprevost F; Barnea E; Yu F; Admon A; Eisenbach L; Samuels Y; Schueler-Furman O; Levin Y; Nesvizhskii AI; Merbl Y
Nat Biotechnol; 2023 Feb; 41(2):239-251. PubMed ID: 36203013
[TBL] [Abstract][Full Text] [Related]
8. Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome.
Brown SD; Holt RA
Oncoimmunology; 2019; 8(3):1556080. PubMed ID: 30723589
[TBL] [Abstract][Full Text] [Related]
9. The HLA Ligandome Comprises a Limited Repertoire of O-GlcNAcylated Antigens Preferentially Associated With HLA-B*07:02.
Mukherjee S; Sanchez-Bernabeu A; Demmers LC; Wu W; Heck AJR
Front Immunol; 2021; 12():796584. PubMed ID: 34925382
[TBL] [Abstract][Full Text] [Related]
10. Are There Indeed Spliced Peptides in the Immunopeptidome?
Admon A
Mol Cell Proteomics; 2021; 20():100099. PubMed ID: 34022431
[TBL] [Abstract][Full Text] [Related]
11. Database search engines and target database features impinge upon the identification of post-translationally cis-spliced peptides in HLA class I immunopeptidomes.
Mishto M; Horokhovskyi Y; Cormican JA; Yang X; Lynham S; Urlaub H; Liepe J
Proteomics; 2022 May; 22(10):e2100226. PubMed ID: 35184383
[TBL] [Abstract][Full Text] [Related]
12. ERAP1 enzyme-mediated trimming and structural analyses of MHC I-bound precursor peptides yield novel insights into antigen processing and presentation.
Li L; Batliwala M; Bouvier M
J Biol Chem; 2019 Dec; 294(49):18534-18544. PubMed ID: 31601650
[TBL] [Abstract][Full Text] [Related]
13. Critical Review of Existing MHC I Immunopeptidome Isolation Methods.
Kuznetsov A; Voronina A; Govorun V; Arapidi G
Molecules; 2020 Nov; 25(22):. PubMed ID: 33228004
[TBL] [Abstract][Full Text] [Related]
14. Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome.
Sturm T; Sautter B; Wörner TP; Stevanović S; Rammensee HG; Planz O; Heck AJR; Aebersold R
J Proteome Res; 2021 Jan; 20(1):289-304. PubMed ID: 33141586
[TBL] [Abstract][Full Text] [Related]
15. A tissue-based draft map of the murine MHC class I immunopeptidome.
Schuster H; Shao W; Weiss T; Pedrioli PGA; Roth P; Weller M; Campbell DS; Deutsch EW; Moritz RL; Planz O; Rammensee HG; Aebersold R; Caron E
Sci Data; 2018 Aug; 5():180157. PubMed ID: 30084848
[TBL] [Abstract][Full Text] [Related]
16. An input-controlled model system for identification of MHC bound peptides enabling laboratory comparisons of immunopeptidome experiments.
Klatt MG; Aretz ZEH; Curcio M; Gejman RS; Jones HF; Scheinberg DA
J Proteomics; 2020 Sep; 228():103921. PubMed ID: 32758705
[TBL] [Abstract][Full Text] [Related]
17. Large-Scale Immunopeptidome Analysis Reveals Recurrent Posttranslational Splicing of Cancer- and Immune-Associated Genes.
Levy R; Alter Regev T; Paes W; Gumpert N; Cohen Shvefel S; Bartok O; Dayan-Rubinov M; Alon M; Shmueli MD; Levin Y; Merbl Y; Ternette N; Samuels Y
Mol Cell Proteomics; 2023 Apr; 22(4):100519. PubMed ID: 36828127
[TBL] [Abstract][Full Text] [Related]
18. Mapping the MHC Class I-Spliced Immunopeptidome of Cancer Cells.
Liepe J; Sidney J; Lorenz FKM; Sette A; Mishto M
Cancer Immunol Res; 2019 Jan; 7(1):62-76. PubMed ID: 30425108
[TBL] [Abstract][Full Text] [Related]
19. VEMS 3.0: algorithms and computational tools for tandem mass spectrometry based identification of post-translational modifications in proteins.
Matthiesen R; Trelle MB; Højrup P; Bunkenborg J; Jensen ON
J Proteome Res; 2005; 4(6):2338-47. PubMed ID: 16335983
[TBL] [Abstract][Full Text] [Related]
20. The yin/yang balance of the MHC-self
Santambrogio L; Franco A
Front Immunol; 2022; 13():1035363. PubMed ID: 36405763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
